apixaban
UkraineDrugs containing this active substance
-
The drug is used for the prevention of venous thromboembolism in adults following elective hip or knee replacement surgery. It is also prescribed for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 2.5 mg ATC: B01AF02
-
The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of recurrence of these conditions.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
-
The drug is used for the prevention of venous thromboembolism in adults following elective hip or knee replacement surgery. It is also prescribed for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 2.5 mg ATC: B01AF02
Manufacturer: Unison Pharmaceuticals Pvt. Ltd. (manufacturing of finished medicinal product, primary and secondary packaging)
-
The drug is used for the prevention of venous thromboembolism in adults following elective hip or knee replacement surgery. It is also indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 2.5 mg ATC: B01AF02
Manufacturer: Farmak JSC
-
The drug is prescribed for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also used for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
Manufacturer: Farmak JSC
-
The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of recurrence of these conditions.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
Manufacturer: Unison Pharmaceuticals Pvt. Ltd. (manufacturing of finished medicinal product, primary and secondary packaging)
-
The drug is used for the prevention of venous thromboembolism in adults following elective hip or knee replacement surgery. It is also prescribed for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 2.5 mg ATC: B01AF02
Manufacturer: Sanovel Ilac Sana ve Ticaret, A.S. (production of finished medicinal product, primary and secondary packaging, batch control)
-
The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.
Form: tablets, film-coated
Active substance Dosage apixaban 5 mg ATC: B01AF02
Manufacturer: Sanovel Ilac Sana ve Ticaret, A.S. (production of finished medicinal product, primary and secondary packaging, batch control)